Table 2.
Biochemical and blood parameters in study groups.
| Parameter |
Healthy controls (n = 60) |
GEC patients | P-value | |
|---|---|---|---|---|
| Noncachectic (n = 41) |
Cachectic (n = 44) |
|||
| Hemoglobin (g/L) | 15.9 ± 1.3a,b | 12.3 ± 1.8c | 11.8 ± 2.0c | <0.001∗ |
| Lymphocytes (109/L) | 2.2 ± 1.3 | 2.9 ± 1.7 | 2.8 ± 1.2 | 0.365 |
| Total protein (g/L) | 69.9 ± 5.9a,b | 58.2 ± 7.1c | 58.2 ± 10.7c | <0.001∗ |
| Albumin (g/L) | 39.2 ± 4.0a | 35.0 ± 7.2c | 37.5 ± 4.8 | 0.039∗ |
| hsCRP (mg/L) | 1.05 ± 0.65a,b | 108.1 ± 53.3c | 110.3 ± 82.9c | <0.001∗ |
| Resistin (ng/mL) | 7.5 ± 2.7b | 8.99 ± 3.21b | 11.74 ± 2.98a,c | <0.001∗ |
| Adiponectin (μg/mL) | 9.81 ± 4.1b | 8.86 ± 3.79 | 8.02 ± 4.10c | 0.248 |
| Apelin (pg/mL) | 635 ± 365b | 820 ± 211 | 855 ± 195c | 0.014∗ |
Data presented as means ± SD and analyzed using ANOVA with post hoc Tukey test.
*Statistically significant; asignificantly different from noncachectic cancer patients; bsignificantly different from cachectic cancer patients; csignificantly different from controls.